Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes
Nicole M. Fisher, Aqeela AlHashim, Aditi B. Buch, Hana Badivuku, Manar M. Samman, Kelly M. Weiss, Gabriela I. Cestero, Mark D. Does, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Rocco G. Gogliotti, Colleen M. Niswender
Nicole M. Fisher, Aqeela AlHashim, Aditi B. Buch, Hana Badivuku, Manar M. Samman, Kelly M. Weiss, Gabriela I. Cestero, Mark D. Does, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Rocco G. Gogliotti, Colleen M. Niswender
View: Text | PDF
Research Article Neuroscience

A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes

  • Text
  • PDF
Abstract

The metabotropic glutamate receptor 7 (mGlu7) is a G protein–coupled receptor that has been recently linked to neurodevelopmental disorders. This association is supported by the identification of GRM7 variants in patients with autism spectrum disorder, attention deficit hyperactivity disorder, and severe developmental delay. One GRM7 mutation previously reported in 2 patients results in a single amino acid change, I154T, within the mGlu7 ligand-binding domain. Here, we report 2 new patients with this mutation who present with severe developmental delay and epilepsy. Functional studies of the mGlu7-I154T mutant reveal that this substitution resulted in significant loss of mGlu7 protein expression in HEK293A cells and in mice. We show that this occurred posttranscriptionally at the level of protein expression and trafficking. Similar to mGlu7–global KO mice, mGlu7-I154T animals exhibited reduced motor coordination, deficits in contextual fear learning, and seizures. This provides functional evidence that a disease-associated mutation affecting the mGlu7 receptor was sufficient to cause neurological dysfunction in mice and further validates GRM7 as a disease-causing gene in the human population.

Authors

Nicole M. Fisher, Aqeela AlHashim, Aditi B. Buch, Hana Badivuku, Manar M. Samman, Kelly M. Weiss, Gabriela I. Cestero, Mark D. Does, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Rocco G. Gogliotti, Colleen M. Niswender

×

Figure 2

The I154T substitution disrupts the interaction of 2 ECDs within an mGlu7 dimer.

Options: View larger image (or click on image) Download as PowerPoint
The I154T substitution disrupts the interaction of 2 ECDs within an mGlu...
(A) Location of isoleucine 154 in the structure of the mGlu7 ECD. PBD 2E4Z. (B) Protein sequence alignment of all 8 human mGlu receptor subtypes. Darker shades of blue indicate increased conservation. (C) Western blot of total protein lysates and media from cells expressing HA-ECD-WT and HA-ECD-I154T constructs in the absence of DTT. (D) Western blot of total protein lysates and media from cells expressing HA-ECD-WT and HA-ECD-I154T constructs in the presence of DTT. (E) Experimental design for cell surface ELISA experiments. (F–H) Quantification of (F) intracellular HA signal, (G) surface HA signal, and (H) surface MYC signal. n = 3 independent experiments with 3 technical replicates each. One-way ANOVA with Tukey’s multiple comparisons. ****P < 0.0001. ns, not significant; ECD, extracellular domain; mGlu7, metabotropic glutamate receptor subtype 7; FL, full-length.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts